CQC registration marks the transition from preparation to sustained regulatory responsibility. CQC registration is often treated as a defining milestone for new medical cannabis clinics. In reality, it marks the beginning of a more sustained and demanding phase of regulatory responsibility. Once registered, clinics move from a model based on declared intentions to one based on demonstrable practice. Governance, leadership, and operational systems are no longer assessed in the

CQC registration assesses whether a service is clinically and operationally ready to deliver safe care. Why CQC Registration Is Often Underestimated For many prospective medical cannabis clinic operators, CQC registration is viewed as a procedural hurdle — a formality to be completed before clinical services can begin. In practice, registration is one of the earliest and most revealing tests of whether a service is operationally and governance-ready. Medical cannabis clinics

Controlled medicine storage and inventory management are central to regulatory expectations for UK medical cannabis clinics. Why Governance Has Become the Defining Issue As the UK medical cannabis sector matures, attention is shifting away from questions of legality and clinical novelty toward the realities of governance. Cannabis-based products for medicinal use (CBPMs) are now firmly established as prescription-only controlled drugs, and clinics operating in this space are

Medical cannabis in the UK continues to develop as regulators, clinicians, and policymakers respond to increasing patient demand and a growing body of clinical evidence. While the legal framework remains tightly controlled, recent regulatory and operational changes are shaping how cannabis-based products for medicinal use (CBPMs) are prescribed, supplied, and governed. For clinics, prescribers, and healthcare organisations operating in this sector, staying informed about th

Medical cannabis in the UK refers specifically to cannabis-based products for medicinal use (CBPMs). These products are manufactured to pharmaceutical standards, prescribed only by specialist clinicians, and supplied through controlled and compliant channels. Although they share origins with the broader cannabis plant, CBPMs differ significantly in formulation, cannabinoid profile, and clinical application. For clinics, prescribers, and operational teams, understanding thes

Clinical consultation in a UK medical setting Opening a medical cannabis clinic in the UK requires more than medical knowledge—it requires navigating a complex regulatory landscape, building compliant governance, and ensuring your services follow CQC-aligned standards from day one. This guide outlines the essential steps involved in launching a safe, compliant and patient-centred medical cannabis service. The introduction of medical cannabis prescribing into UK clinical prac